• Agenda
    • Get Involved
    • Programs
    • In-Person Group Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Training Seminars
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target Mobile
sponsorship-exhibit-banner
Demographics Sponsors Opportunities Exhibits Lead Gen FAQ

Sponsors

Premier Sponsors

Wuxi_Biortus Causaly Charles-River  GenScript-ProBio

Corporate Sponsors

AbCheck-logo  AssayQuantTechnologies dot212600-cellecta-inc-companyLogo-WebReadyCollaborative Drug DiscoveryChemical_Computing_Group GENOVACLifeSensors-phone OmniAb  PelagoPivot_ParkQ2_Solutions_NoTaglineReactionBiology_2021 SGS Wuxi-Apptec x-chem_Pharmaceuticals Xtalpi ZoBio-New-Small

Corporate Support Sponsors

 bioascent Biointron_new biosensing-instrument-logo BPS-Bioscience CarterraChempartner  CovaLXCreative_BioMart CuriaCusaBio TechnologyDeltabio Enamine Eurofins_Advinus Fusion-Antibodies_horizontal Immuto ImmunoPrecise_New IRBM_10thAnniversary Laxai_new  Liverpool_ChirochemNanotemperTechnologies Promega ProteomeSciences Sai SelvitaSinoBiological_no tagline SpiroChem STEMCELL-Technologies Syngene_taglineTargetMol


Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT23


Register Early for Maximum Savings
Stay up to Date on our 2023 Program
Download Brochure
2023 Programs
View All Sponsors
View Media Partners

September 25

Emerging Immune Modulation Strategies

Strategies for Targeting Kinases

September 26-27

Protein Degraders and Molecular Glues – Part 1

Proteomics-Driven Drug Discovery

Small Molecules Targeting RNA

Small Molecules for Cancer Targets – Part 1

Neurodegeneration Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

AI/ML-Enabled Drug Discovery – Part 1

September 27-28

Protein Degraders and Molecular Glues – Part 2

Genomics-Driven Drug Discovery

Targeting Transcription Factors

Small Molecules for Cancer Targets – Part 2

Fibrosis and Inflammation

Lead Generation Strategies

Antibodies Against Membrane Protein Targets – Part 2

AI/ML-Enabled Drug Discovery – Part 2

The Renaissance in GPCRs as Drug Targets: Allosteric Function and Biased Signaling

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation, and Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy